By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


BioMarin Pharmaceutical Inc. 

105 Digital Drive

Novato  California  94949  U.S.A.
Phone: 415-506-6700 Fax: 415-382-7427



Company News
BioMarin (BMRN) To Present Research Results On Duchenne Muscular Dystrophy And Pompe Disease Programs At The 20th International Congress Of The World Muscle Society 10/1/2015 7:58:03 AM
BioMarin (BMRN) Reacquires Kuvan from Merck Serono in Deal Worth More than $500 Million 10/1/2015 5:53:56 AM
Sarepta (SRPT) Announces USPTO Decision In Patent Interference Case With BioMarin (BMRN) 9/30/2015 12:15:43 PM
BioMarin (BMRN) Receives Favorable Ruling In The Use Of Exon 51 Antisense Oligonucleotides Patent Interference 9/30/2015 7:10:16 AM
BioMarin (BMRN) Enrolls First Patient In Phase I/II Trial Of Gene Therapy Drug Candidate BMN 270 For The Treatment Of Hemophilia A 9/29/2015 6:50:54 AM
BioMarin (BMRN) Announces Kuvan (Sapropterin Dihydrochloride) Patent Challenge Settlement 9/21/2015 7:21:21 AM
BioMarin (BMRN) To Attend Upcoming Investor Conferences In September 9/2/2015 7:40:34 AM
BioMarin (BMRN) Launches Knowyourduchenne, Comprehensive Program For Patients With Duchenne Muscular Dystrophy To Understand Their Genetic Mutation 9/1/2015 8:31:56 AM
BioMarin (BMRN) Announces Two Oral And 19 Poster Presentations At The Society For The Study Of Inborn Errors Of Metabolism 2015 Annual Meeting 8/31/2015 7:28:57 AM
Medivation (MDVN) To Expand Global Oncology Franchise With The Acquisition Of All Worldwide Rights To Talazoparib (BMN 673), A Potent PARP Inhibitor, From BioMarin (BMRN) 8/24/2015 10:07:35 AM